{"organizations": [], "uuid": "75d852903c541d979f9a6a4b5d45a6e56d68175f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-lilly-and-chinas-nccd-announce-col/brief-lilly-and-chinas-nccd-announce-collaboration-to-advance-scientific-understanding-and-care-for-people-living-with-diabetes-and-cardiovascular-disease-idUSFWN1S20QE", "country": "US", "domain_rank": 408, "title": "BRIEF-Lilly And China's NCCD Announce Collaboration To Advance Scientific Understanding And Care For People Living With Diabetes And Cardiovascular Disease", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-25T13:53:00.000+03:00", "replies_count": 0, "uuid": "75d852903c541d979f9a6a4b5d45a6e56d68175f"}, "author": "", "url": "https://www.reuters.com/article/brief-lilly-and-chinas-nccd-announce-col/brief-lilly-and-chinas-nccd-announce-collaboration-to-advance-scientific-understanding-and-care-for-people-living-with-diabetes-and-cardiovascular-disease-idUSFWN1S20QE", "ord_in_thread": 0, "title": "BRIEF-Lilly And China's NCCD Announce Collaboration To Advance Scientific Understanding And Care For People Living With Diabetes And Cardiovascular Disease", "locations": [], "entities": {"persons": [{"name": "eli lilly", "sentiment": "none"}, {"name": "lilly", "sentiment": "none"}], "locations": [{"name": "united states", "sentiment": "none"}, {"name": "china", "sentiment": "none"}, {"name": "china", "sentiment": "none"}], "organizations": [{"name": "people living with diabetes and cardiovascular disease reuters", "sentiment": "neutral"}, {"name": "nccd", "sentiment": "neutral"}, {"name": "nccd announce co", "sentiment": "neutral"}, {"name": "eli lilly", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "cardiovascular diseases & co", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 25 (Reuters) - Eli Lilly and Co:\n* LILLY AND CHINA’S NCCD ANNOUNCE COLLABORATION TO ADVANCE SCIENTIFIC UNDERSTANDING AND CARE FOR PEOPLE LIVING WITH DIABETES AND CARDIOVASCULAR DISEASE\n* ELI LILLY - DEAL BETWEEN CHINA’S NATIONAL CENTER FOR CARDIOVASCULAR DISEASES & CO AIMS TO IMPROVE CARE FOR PEOPLE LIVING WITH TYPE 2 DIABETES IN CHINA\n* ELI LILLY - PLANS TO COLLABORATE ACROSS 4 INITIATIVES TO ADVANCE SCIENTIFIC UNDERSTANDING OF TYPE 2 DIABETES & RELATED COMPLICATIONS Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-04-25T13:53:00.000+03:00", "crawled": "2018-04-25T14:02:39.003+03:00", "highlightTitle": ""}